Lilly’s Imclone acquisition could close Monday
Eli Lilly and Co. won more than 95.5 percent of the shares of New York-based ImClone Systems Inc. in a tender offer that ended at midnight yesterday. Lilly expects to complete its acquisition of ImClone on Monday. Indianapolis-based Lilly has agreed to pay $70 in cash for each share of ImClone, or $6.3 billion for […]